{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:04:12Z","timestamp":1791259452779,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2002,9,1]]},"DOI":"10.1038\/sj.mp.4001093","type":"journal-article","created":{"date-parts":[[2002,9,24]],"date-time":"2002-09-24T10:57:49Z","timestamp":1032865069000},"page":"837-844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":392,"title":["NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors\u2014implications for models of schizophrenia"],"prefix":"10.1038","volume":"7","author":[{"given":"S","family":"Kapur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Seeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,9,17]]},"reference":[{"key":"BF4001093_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/026988119901300405","volume":"13","author":"M Laruelle","year":"1999","unstructured":"Laruelle M, Abi-Dargham A . Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies J Psychopharmacol 1999; 13: 358\u2013371","journal-title":"J Psychopharmacol"},{"key":"BF4001093_CR2","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1073\/pnas.97.14.7673","volume":"97","author":"P Seeman","year":"2000","unstructured":"Seeman P, Kapur S . Schizophrenia: more dopamine, more D2 receptors Proc Natl Acad Sci U S A 2000; 97: 7673\u20137675","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BF4001093_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","volume":"158","author":"S Kapur","year":"2001","unstructured":"Kapur S, Seeman P . Does fast dissociation from the dopamine D2 receptors explain atypical antipsychotic action\u2014a new hypothesis Am J Psychiatry 2001; 158: 360\u2013369","journal-title":"Am J Psychiatry"},{"key":"BF4001093_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0304-3940(80)90178-0","volume":"20","author":"JS Kim","year":"1980","unstructured":"Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B . Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neurosci Lett 1980; 20: 379\u2013382","journal-title":"Neurosci Lett"},{"key":"BF4001093_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","volume":"13","author":"M Carlsson","year":"1990","unstructured":"Carlsson M, Carlsson A . Interactions between glutamatergic and monoaminergic systems within the basal ganglia\u2014implications for schizophrenia and Parkinson's disease Trends Neurosci 1990; 13: 272\u2013276","journal-title":"Trends Neurosci"},{"key":"BF4001093_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0165-0173(99)00050-8","volume":"31","author":"A Carlsson","year":"2000","unstructured":"Carlsson A, Waters N, Waters S, Carlsson ML . Network interactions in schizophrenia\u2014therapeutic implications Brain Res Brain Res Rev 2000; 31: 342\u2013349","journal-title":"Brain Res Brain Res Rev"},{"key":"BF4001093_CR7","first-page":"16","volume":"1","author":"DC Javitt","year":"1996","unstructured":"Javitt DC . Glutamate receptors and schizophrenia: opportunities and caveats Mol Psychiatry 1996; 1: 16\u201317","journal-title":"Mol Psychiatry"},{"key":"BF4001093_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","volume":"20","author":"JD Jentsch","year":"1999","unstructured":"Jentsch JD, Roth RH . The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 1999; 20: 201\u2013225","journal-title":"Neuropsychopharmacology"},{"key":"BF4001093_CR9","first-page":"289","volume-title":"Antipsychotics","author":"NR Swerdlow","year":"1996","unstructured":"Swerdlow NR, Braff DL, Bakshi VP, Geyer MA . An animal model of sensorimotor gating deficits in schizophrenia predicts antipsychotic drug action In: Csernansky JG (ed) Antipsychotics Heidelberger Platz 3\/W-1000 Berlin 33\/Germany: Springer-Verlag: Berlin 1996; pp 289\u2013312"},{"key":"BF4001093_CR10","first-page":"475","volume":"20","author":"HP Kari","year":"1978","unstructured":"Kari HP, Davidson PP, Kohl HH, Kochhar MM . Effects of ketamine on brain monoamine levels in rats Res Commun Chem Pathol Pharmacol 1978; 20: 475\u2013488","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"BF4001093_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF00499447","volume":"295","author":"SN Glisson","year":"1976","unstructured":"Glisson SN, el-Etr AA, Bloor BC . The effect of ketamine upon norepinephrine and dopamine levels in rabbit brain parts Naunyn Schmiedebergs Arch Pharmacol 1976; 295: 149\u2013152","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF4001093_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/1098-2396(200008)37:2<95::AID-SYN3>3.0.CO;2-H","volume":"37","author":"H Tsukada","year":"2000","unstructured":"Tsukada H, Harada N, Nishiyama S, Ohba H, Sato K, Fukumoto D et al. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis Synapse 2000; 37: 95\u2013103","journal-title":"Synapse"},{"key":"BF4001093_CR13","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1016\/0006-2952(88)90639-9","volume":"37","author":"T Nabeshima","year":"1988","unstructured":"Nabeshima T, Ishikawa K, Yamaguchi K, Furukawa H, Kameyama T . Protection with phencyclidine against inactivation of 5-HT2 receptors by sulfhydryl-modifying reagents Biochem Pharmacol 1988; 37: 3277\u20133283","journal-title":"Biochem Pharmacol"},{"key":"BF4001093_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0892-0362(94)90022-1","volume":"16","author":"RB Rothman","year":"1994","unstructured":"Rothman RB . PCP site 2: a high affinity MK-801-insensitive phencyclidine binding site Neurotoxicol Teratol 1994; 16: 343\u2013353","journal-title":"Neurotoxicol Teratol"},{"key":"BF4001093_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/00000542-199803000-00029","volume":"88","author":"M Nishimura","year":"1998","unstructured":"Nishimura M, Sato K, Okada T, Yoshiya I, Schloss P, Shimada S et al. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells Anesthesiology 1998; 88: 768\u2013774","journal-title":"Anesthesiology"},{"key":"BF4001093_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1210\/endo-117-2-690","volume":"117","author":"SR George","year":"1985","unstructured":"George SR, Watanabe M, Di Paolo T, Falardeau P, Labrie F, Seeman P . The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form Endocrinology 1985; 117: 690\u2013697","journal-title":"Endocrinology"},{"key":"BF4001093_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1471-4159.1984.tb06700.x","volume":"43","author":"P Seeman","year":"1984","unstructured":"Seeman P, Ulpian C, Wreggett KA, Wells JW . Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examples J Neurochem 1984; 43: 221\u2013235","journal-title":"J Neurochem"},{"key":"BF4001093_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0169-328X(00)00064-4","volume":"77","author":"IS Liu","year":"2000","unstructured":"Liu IS, George SR, Seeman P . The human dopamine D2(Longer) receptor has a high-affinity state and inhibits adenylyl cyclase Brain Res Mol Brain Res 2000; 77: 281\u2013284","journal-title":"Brain Res Mol Brain Res"},{"key":"BF4001093_CR19","first-page":"790","volume":"274","author":"A Malmberg","year":"1995","unstructured":"Malmberg A, Mohell N . Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides J Pharmacol Exp Ther 1995; 274: 790\u2013797","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4001093_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0922-4106(94)90212-7","volume":"266","author":"RG MacKenzie","year":"1994","unstructured":"MacKenzie RG, VanLeeuwen D, Pugsley TA, Shih YH, Demattos S, Tang L et al. Characterization of the human dopamine D3 receptor expressed in transfected cell lines Eur J Pharmacol 1994; 266: 79\u201385","journal-title":"Eur J Pharmacol"},{"key":"BF4001093_CR21","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/0006-2952(85)90526-X","volume":"34","author":"M Watanabe","year":"1985","unstructured":"Watanabe M, George SR, Seeman P . Dependence of dopamine receptor conversion from agonist high- to low-affinity state on temperature and sodium ions Biochem Pharmacol 1985; 34: 2459\u20132463","journal-title":"Biochem Pharmacol"},{"key":"BF4001093_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0165-6147(93)90048-O","volume":"14","author":"RJ Lefkowitz","year":"1993","unstructured":"Lefkowitz RJ, Cotecchia S, Samama P, Costa T . Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins Trends Pharmacol Sci 1993; 14: 303\u2013307","journal-title":"Trends Pharmacol Sci"},{"key":"BF4001093_CR23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/sj.bjp.0701926","volume":"124","author":"B Gardner","year":"1998","unstructured":"Gardner B, Strange PG . Agonist action at D2(long) dopamine receptors: ligand binding and functional assays Br J Pharmacol 1998; 124: 978\u2013984","journal-title":"Br J Pharmacol"},{"key":"BF4001093_CR24","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S0006-3223(01)01110-6","volume":"49","author":"S Kapur","year":"2001","unstructured":"Kapur S, Seeman P . Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor Biol Psychiatry 2001; 49: 954\u2013957","journal-title":"Biol Psychiatry"},{"key":"BF4001093_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0304-3940(99)00688-6","volume":"274","author":"M Nishimura","year":"1999","unstructured":"Nishimura M, Sato K . Ketamine stereoselectively inhibits rat dopamine transporter Neurosci Lett 1999; 274: 131\u2013134","journal-title":"Neurosci Lett"},{"key":"BF4001093_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3940(90)90329-8","volume":"112","author":"DC Martin","year":"1990","unstructured":"Martin DC, Introna RP, Aronstam RS . Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter Neurosci Lett 1990; 112: 99\u2013103","journal-title":"Neurosci Lett"},{"key":"BF4001093_CR27","first-page":"129","volume":"62","author":"DC Martin","year":"1988","unstructured":"Martin DC, Adams RJ, Watkins CA . Inhibition of synaptosomal serotonin uptake by Ketalar Res Commun Chem Pathol Pharmacol 1988; 62: 129\u2013132","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"BF4001093_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00000542-199801000-00015","volume":"88","author":"TA Bowdle","year":"1998","unstructured":"Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP . Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations Anesthesiology 1998; 88: 82\u201388","journal-title":"Anesthesiology"},{"key":"BF4001093_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/bja\/70.6.666","volume":"70","author":"G Geisslinger","year":"1993","unstructured":"Geisslinger G, Hering W, Thomann P, Knoll R, Kamp HD, Brune K . Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method Br J Anaesth 1993; 70: 666\u2013671","journal-title":"Br J Anaesth"},{"key":"BF4001093_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1213\/00000539-198202000-00004","volume":"61","author":"EF Domino","year":"1982","unstructured":"Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, Domino SE . Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay Anesth Analg 1982; 61: 87\u201392","journal-title":"Anesth Analg"},{"key":"BF4001093_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/bja\/51.12.1167","volume":"51","author":"J Idvall","year":"1979","unstructured":"Idvall J, Ahlgren I, Aronsen KR, Stenberg P . Ketamine infusions: pharmacokinetics and clinical effects Br J Anaesth 1979; 51: 1167\u20131173","journal-title":"Br J Anaesth"},{"key":"BF4001093_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3959(98)00269-3","volume":"81","author":"M Shimoyama","year":"1999","unstructured":"Shimoyama M, Shimoyama N, Gorman AL, Elliott KJ, Inturrisi CE . Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine Pain 1999; 81: 85\u201393","journal-title":"Pain"},{"key":"BF4001093_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20","volume":"12","author":"CA Tamminga","year":"1998","unstructured":"Tamminga CA . Schizophrenia and glutamatergic transmission Crit Rev Neurobiol 1998; 12: 21\u201336","journal-title":"Crit Rev Neurobiol"},{"key":"BF4001093_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/schbul\/16.3.425","volume":"16","author":"M Carlsson","year":"1990","unstructured":"Carlsson M, Carlsson A . Schizophrenia: a subcortical neurotransmitter imbalance syndrome? [Review] Schizophr Bull 1990; 16: 425\u2013432","journal-title":"Schizophr Bull"},{"key":"BF4001093_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00000542-199901000-00023","volume":"90","author":"K Hirota","year":"1999","unstructured":"Hirota K, Okawa H, Appadu BL, Grandy DK, Devi LA, Lambert DG . Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells Anesthesiology 1999; 90: 174\u2013182","journal-title":"Anesthesiology"},{"key":"BF4001093_CR36","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","volume":"281","author":"B Moghaddam","year":"1998","unstructured":"Moghaddam B, Adams BW . Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 1998; 281: 1349\u20131352","journal-title":"Science"},{"key":"BF4001093_CR37","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 1997; 17: 2921\u20132927","journal-title":"J Neurosci"},{"key":"BF4001093_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","volume":"24","author":"NR Swerdlow","year":"1998","unstructured":"Swerdlow NR, Geyer MA . Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia Schizophr Bull 1998; 24: 285\u2013301","journal-title":"Schizophr Bull"},{"key":"BF4001093_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s002130050741","volume":"140","author":"NR Swerdlow","year":"1998","unstructured":"Swerdlow NR, Bakshi V, Waikar M, Taaid N, Geyer MA . Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats Psychopharmacol (Berl) 1998; 140: 75\u201380","journal-title":"Psychopharmacol (Berl)"},{"key":"BF4001093_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF02245171","volume":"107","author":"A Verma","year":"1992","unstructured":"Verma A, Kulkarni SK . Modulation of MK-801 response by dopaminergic agents in mice Psychopharmacology 1992; 107: 431\u2013436","journal-title":"Psychopharmacology"},{"key":"BF4001093_CR41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/j.1552-4604.1984.tb01831.x","volume":"24","author":"AJ Giannini","year":"1984","unstructured":"Giannini AJ, Eighan MS, Loiselle RH, Giannini MC . Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis J Clin Pharmacol 1984; 24: 202\u2013204","journal-title":"J Clin Pharmacol"},{"key":"BF4001093_CR42","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3109\/15563658408992586","volume":"22","author":"AJ Giannini","year":"1984","unstructured":"Giannini AJ, Nageotte C, Loiselle RH, Malone DA, Price WA . Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity J Toxicol Clin Toxicol 1984; 22: 573\u2013579","journal-title":"J Toxicol Clin Toxicol"},{"key":"BF4001093_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/15563658508990627","volume":"23","author":"AJ Giannini","year":"1985","unstructured":"Giannini AJ, Price WA, Loiselle RH, Malone DW . Treatment of phenylcyclohexylpyrrolidine (PHP) psychosis with haloperidol J Toxicol Clin Toxicol 1985; 23: 185\u2013189","journal-title":"J Toxicol Clin Toxicol"},{"key":"BF4001093_CR44","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1046\/j.1460-9568.1999.00858.x","volume":"11","author":"MJ Millan","year":"1999","unstructured":"Millan MJ, Brocco M, Gobert A, Joly F, Bervoets K, Rivet J et al. Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat Eur J Neurosci 1999; 11: 4419\u20134432","journal-title":"Eur J Neurosci"},{"key":"BF4001093_CR45","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","volume":"321","author":"J Geddes","year":"2000","unstructured":"Geddes J, Freemantle N, Harrison P, Bebbington P . Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis BMJ 2000; 321: 1371\u20131376","journal-title":"BMJ"},{"key":"BF4001093_CR46","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/S0006-3223(98)00356-4","volume":"46","author":"S Yamada","year":"1999","unstructured":"Yamada S, Harano M, Annoh N, Nakamura K, Tanaka M . Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats Biol Psychiatry 1999; 46: 832\u2013838","journal-title":"Biol Psychiatry"},{"key":"BF4001093_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF01276460","volume":"100","author":"ML Carlsson","year":"1995","unstructured":"Carlsson ML . The selective 5-HT2a receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse\u2014implications for psychosis J Neural Transm\u2014Gen Sect 1995; 100: 225\u2013237","journal-title":"J Neural Transm\u2014Gen Sect"},{"key":"BF4001093_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0893-133X(97)00126-7","volume":"18","author":"VL Arvanov","year":"1998","unstructured":"Arvanov VL, Wang RY . M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro Neuropsychopharmacology 1998; 18: 197\u2013209","journal-title":"Neuropsychopharmacology"},{"key":"BF4001093_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0893-133X(98)00003-7","volume":"19","author":"RY Wang","year":"1998","unstructured":"Wang RY, Liang X . M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice Neuropsychopharmacology 1998; 19: 74\u201385","journal-title":"Neuropsychopharmacology"},{"key":"BF4001093_CR50","first-page":"666","volume":"283","author":"VP Bakshi","year":"1997","unstructured":"Bakshi VP, Geyer MA . Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist J Pharmacol Exp Ther 1997; 283: 666\u2013674","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4001093_CR51","unstructured":"Announcement. Management decisions on priority pipeline products\u2014MDL 100907 In Vision Extra 1999; pp 2\u20133"},{"key":"BF4001093_CR52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1176\/ajp.156.3.419","volume":"156","author":"P Truffinet","year":"1999","unstructured":"Truffinet P, Tamminga CA, Fabre LF, Meltzer HY, Riviere ME, Papillon-Downey C . Placebo-controlled study of the D4\/5-HT2A antagonist fananserin in the treatment of schizophrenia Am J Psychiatry 1999; 156: 419\u2013425","journal-title":"Am J Psychiatry"},{"key":"BF4001093_CR53","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/BF00965013","volume":"11","author":"E Toth","year":"1986","unstructured":"Toth E, Lajtha A . Antagonism of phencyclidine-induced hyperactivity by glycine in mice Neurochem Res 1986; 11: 393\u2013400","journal-title":"Neurochem Res"},{"key":"BF4001093_CR54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1254\/jjp.62.111","volume":"62","author":"H Kuribara","year":"1993","unstructured":"Kuribara H, Uchihashi Y . SCH 23390 equivalently, but YM-09151-2 differentially reduces the stimulant effects of methamphetamine, MK-801 and ketamine: assessment by discrete shuttle avoidance in mice Jpn J Pharmacol 1993; 62: 111\u2013114","journal-title":"Jpn J Pharmacol"},{"key":"BF4001093_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0091-3057(94)90554-1","volume":"48","author":"DM Jackson","year":"1994","unstructured":"Jackson DM, Johansson C, Lindgren LM, Bengtsson A . Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats Pharmacol Biochem Behav 1994; 48: 465\u2013471","journal-title":"Pharmacol Biochem Behav"},{"key":"BF4001093_CR56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s002130051049","volume":"145","author":"JH Krystal","year":"1999","unstructured":"Krystal JH, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D et al. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans Psychopharmacol (Berl) 1999; 145: 193\u2013204","journal-title":"Psychopharmacol (Berl)"},{"key":"BF4001093_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0304-3940(87)90425-3","volume":"76","author":"T Nabeshima","year":"1987","unstructured":"Nabeshima T, Ishikawa K, Yamaguchi K, Furukawa H, Kameyama T . Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats Neurosci Lett 1987; 76: 335\u2013338","journal-title":"Neurosci Lett"},{"key":"BF4001093_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0893-133X(98)00072-4","volume":"20","author":"GB Varty","year":"1999","unstructured":"Varty GB, Bakshi VP, Geyer MA . M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats Neuropsychopharmacology 1999; 20: 311\u2013321","journal-title":"Neuropsychopharmacology"},{"key":"BF4001093_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0893-133X(98)00003-7","volume":"19","author":"RY Wang","year":"1998","unstructured":"Wang RY, Liang X . M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice Neuropsychopharmacology 1998; 19: 74\u201385","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4001093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001093","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:31:33Z","timestamp":1682357493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,1]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,9,1]]}},"alternative-id":["BF4001093"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4001093","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9,1]]},"assertion":[{"value":"30 April 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2001","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2002","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2002","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}